Drug comparisons
Tolazamide vs Vildagliptin
Compare Tolazamide and Vildagliptin for type 2 diabetes: sulfonylurea vs DPP-4 inhibitor. Learn about efficacy, hypoglycemia risks, and which might be better.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes exploring oral medication options, particularly when considering older sulfonylureas versus newer DPP-4 inhibitors.
Bottom line
Vildagliptin generally offers a better safety profile than Tolazamide, but treatment should be individualized.
All medication comparisons